8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)
Published . Updated .
Filed: 2026-10-15 AccNo: 0001193125-26-422929 Size: 990 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Directly affected
- TRAX First Tracks Biotherapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-15 AccNo: 0001193125-26-422929 Size: 990 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exh…
Source: sec-edgar
Price since this story was published: First Tracks Biotherapeutics (TRAX)
Since the first closing price after “8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer),” First Tracks Biotherapeutics (TRAX) is +4.99%. The S&P 500 fund (SPY) is +0.43% over the same days, a +4.56% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.17% | final price |
| GLD | the next day | -0.79% | final price |
| GLD | two days later | -1.15% | still updating |
| GLD | three days earlier | -0.27% | final price |
| GLD | five days earlier | +0.50% | final price |
| QQQ | that day | -2.52% | final price |
| QQQ | the next day | -1.36% | final price |
| QQQ | two days later | -1.67% | still updating |
| QQQ | three days earlier | +2.12% | final price |
| QQQ | five days earlier | +3.17% | final price |
| SPY | that day | -1.09% | final price |
| SPY | the next day | -0.67% | final price |
| SPY | two days later | -0.49% | still updating |
| SPY | three days earlier | +0.81% | final price |
| SPY | five days earlier | +0.87% | final price |
| TLT | that day | +0.06% | final price |
| TLT | the next day | -0.66% | final price |
| TLT | two days later | +0.16% | still updating |
| TLT | three days earlier | -2.05% | final price |
| TLT | five days earlier | -2.54% | final price |
| First Tracks Biotherapeutics (TRAX) | that day | -4.29% | final price |
| First Tracks Biotherapeutics (TRAX) | the next day | +0.67% | final price |
| First Tracks Biotherapeutics (TRAX) | two days later | +7.48% | still updating |
| First Tracks Biotherapeutics (TRAX) | three days earlier | -12.12% | final price |
| First Tracks Biotherapeutics (TRAX) | five days earlier | -11.64% | final price |
Who gains and who loses around First Tracks Biotherapeutics (TRAX)
Companies mentioned with this story
- TRAX First Tracks Biotherapeutics
For “8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer),” First Tracks Biotherapeutics (TRAX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> TRAX
First Tracks Biotherapeutics (TRAX)
The 15 Oct 2026 story “8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)” names First Tracks Biotherapeutics (TRAX) because of this story.
What ties First Tracks Biotherapeutics (TRAX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> TRAX
Dates and price levels for First Tracks Biotherapeutics (TRAX)
TRAX traded between 30.37 and 42.23 across 20 sessions. The latest close on file is 36.22.
A simple score for First Tracks Biotherapeutics (TRAX)
21 out of 100Price not final
“8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)” scores 21 out of 100. The score uses 1 sources, a +1.34% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.